7
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Ouabain-Like and Non-Ouabain-Like Factors in Plasma of Patients with Essential Hypertension

, , &
Pages 1233-1242 | Published online: 03 Jul 2009

References

  • Haddy F. J., Overbeck H. W. The role of humoral agents in volume expanded hypertension. Life Sci. 1976; 19: 935–948
  • Blaustein M. P. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am. J. Physiol. 1977; 232: c165–c173
  • de Wardener H. E., MacGregor G. A. The Natriuretic hormone and essential hypertension. Lancet 1982; i: 1450–1454
  • Gruber K. A., Whitaker J. M., Buckalew V. M., Jr. Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature 1980; 287: 743–745
  • Clarkson E. M., de Wardener H. E. Observations on a low molecular weight natriuretic and Na-K-ATPase inhibitory material in urine. Clin. Exp. Hypert. 1985; 7: 673–683
  • Crabos M., Wainer I. W., Cloix J. F. Measurement of endogenous Na+-K+-ATPase inhibitors in human plasma and urine using high-performance liquid chromatography. FEBS Lett. 1984; 176: 223–228
  • Weiler E., Tuck M., Gonick H. C. Observations on the “cascade” of Na-K-ATPase inhibitory and digoxin-like immunoreaetive material in human urine: Possible relevance to essential hypertension. Clin. Exp. Hypert. 1985; 7: 809–830
  • Kramer H. J., Heppe M., Weiler E., Baecker A., Liddiard C., Klingmuller D. Further characterization of the endogenous natriuretic and digoxin-like immunoreacting activities in human urine: effects of changes in sodium intake. Renal Physiol., Basel 1985; 8: 80–89
  • Henning G., Cloix J. F., Wainer I. W., Pernollet M. G., Devynck M. A., Meyer P. Affinity chromatography for human Na+,K+-ATPase inhibitors in plasma and urine. Life Sci. 1985; 36: 1787–1798
  • Kojima I. Circulating digitalis-like substance is increased in Docasalt hypertension. Biochem. Biophys. Res. Commun. 1984; 122: 129–136
  • Pamnani M. B., Haddy F. J. Characteristics of hypertensive patients with increased plasma Na+-K+ pump inhibitory activity. Clin. Exp. Hypert. 1985; 7: 755–768
  • Wainer I. W. Rapid large-scale isolation of biologically active molecules using reversed-phase “flash” chromatography: initial purification of endogenous Na+, K+-ATPase inhibitors from human urine. J. Chromatography 1985; 338: 417–421
  • Lichtstein D., Samuelov S. Endogenous “ouabain like” activity in rat brain. Biochem. Biophys. Res. Commun. 1980; 96: 1518–1523
  • de Pover A., Castaneda-Hernandez G., Godfraind T. Water versus acetone-HC1 extraction of digitalis-like factor from guinea-pig heart. Biochem. Pharmacol. 1982; 31: 267–271
  • Haupert G. T., Sancho J. M., Jr. Sodium transport inhibitor from bovine hypothalamus. Proc. Nat. Acad. Sci. USA 1979; 76: 4658–4660
  • Hillyard S. D., Lu E., Gonick H. C. Further characterization of the natriuretic factor derived from kidney tissue of volume-expanded rats. Circ. Res. 1976; 38: 250–255
  • Fagoo M., Godfraind T. Further characterization of cardiodigin, Na+, K+-ATPase inhibitor extracted from mammalian tissues. FEBS Lett. 1985; 184: 150–154
  • Masugi F., Ogihara T., Hasegawa T., Tomii A., Nagano M., Higashimori K., Kumahara Y., Terano Y. Circulating inhibitor with ouabain-like immunoreactivity in patients with primary aldosteronism. Biochem. Biophys. Res. Commun. 1986; 135: 41–45
  • Masugi F., Ogihara T., Hasegawa T., Imai N., Nagano M., Tabuchi Y., Kumahara Y. Sensitive assay and kinetic property of urinary inhibitor of Na+,K+-ATPase inhibitor in sodium loaded patients with essential hypertension Jpn. Circ. J. 1985; 49: 980–983
  • Kracke G. R. Na+,K+-ATPase inhibitor from guinea pig brain is not ouabain-like. J. Lab. Clin. Med. 1983; 101: 105–113
  • Hamlyn J. M., Ringel R., Schaeffer J., Levinson P. D., Hamilton B. P., Kowarski A. A., Blaustein M. P. A circulating inhibitor of (Na+, K+)ATPase associated with essential hypertension. Nature 1982; 300: 650–652

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.